(Q50565055)

English

Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine.

scientific article published in October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

chronic obstructive pulmonary disease

1 reference

based on heuristic

1 reference

based on heuristic

2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

author name string

Senderovitz T

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

Frandsen J

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

Maltbaek N

4

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

Nørgaard M

5

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

Nielsen C

6

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

Kampmann JP

7

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

Respiratory Medicine

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

93

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

10

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

715-718

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

Systemic corticosteroids in COPD. An unresolved clinical dilemma.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Steroid response in stable chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Steroid trials in the assessment of reversibility of air flow limitation: a survey of current clinical practice of chest physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Corticosteroids in stable chronic obstructive pulmonary disease: reappraisal of efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflo

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of long-term treatment with corticosteroids in COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990038-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0954-6111(99)90038-0

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/10581660

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50565055&oldid=1412373317"